Company & Sponsor Intelligence

Fondation Ophtalmologique Adolphe de Rothschild

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials9

Recruiting3

Completed5

Countries1

Therapeutic footprint

epilepsypain_neuropathyparkinsons

Indexed studies

NCT02894333Action-effect Anticipation in Patients With Parkinson's Disease : A Study of the Sensory Attenuation Marker.
parkinsons · FranceTERMINATED

NCT05523531Prospective Single-center Long-term Follow-up Study of a Series of Cases Previously Included in the QUALVIDON Study
pain_neuropathy · FranceCOMPLETED

NCT04648150Evaluation of a Millimeter Wave Emission Bracelet for Improving Parkinson's Disease Symptoms
parkinsons · FranceNA

NCT06898749Impact of Canine Mediation Practice in Psychomotor Therapy on Improving the Quality of Life in Adult Epileptic Patients.
epilepsy · NA

NCT02896608Neuronal Excitability of HCN1 Channel Mutations in Dravet Syndrome
epilepsy · FranceCOMPLETED

NCT02898935Improvement of the Accuracy of Spatial Representation of Invasive Exploratory Electrodes in Focal Epilepsy
epilepsy · FranceCOMPLETED

NCT04451278RESting-state Functional MRI for Prediction of Post-surgical Prognosis In Pediatric Drug-Resistant Epilepsy
epilepsy · FranceRECRUITING

NCT02907723Feasibility of Continuous Sleep Recording in Patients Undergoing Deep Brain Stimulation for Parkinson's Disease
parkinsons · NA

NCT07316972CEST-based Biomarkers to Delineate the Epileptogenic Zone
epilepsy · NA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →